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Abstract Poly(ADP-ribose)polymerase is a nuclear NAD-
dependent enzyme and an essential nick sensor involved in
cellular processes where nicking and rejoining of DNA strands
are required. The inter-K-inhibitor family is comprized of several
plasma proteins that all harbor one or more so-called heavy
chains designated H1^H4. The latter originate from precursor
polypeptides H1P^H4P whose upper two thirds are highly
homologous. We now describe a novel protein that includes (i) a
so-called BRCT domain found in many proteins involved in DNA
repair, (ii) an area that is homologous to the NAD-dependent
catalytic domain of poly(ADP-ribose)polymerase, (iii) an area
that is homologous to the upper two thirds of precursor
polypeptides H1P^H4P and (iv) a proline-rich region with a
potential nuclear localization signal. This protein now designated
PH5P points to as yet unsuspected links between poly(ADP-
ribose)polymerase and the inter-K-inhibitor family and is likely
to be involved in DNA repair.
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1. Inter-K-inhibitor (IKI) family
A protein family consists of proteins that share at least 40%
identical or conservative amino acid residues whereas a super-
family is made up of proteins that share a lower level of
conservation along with a still unambiguous evolutionary re-
lationship. The set of plasma proteins comprized of IKI and
related molecules is collectively referred to as the IKI family.
Our knowledge of this family is currently expanding in three
directions, including novel structural features for the genes
and proteins, insights of some regulatory steps involved in
their mostly hepatic expression and, albeit to a lesser extent,
an appraisal of functions for some family members in health
and disease such as stabilization of extracellular matrices by
virtue of a hyaluronan binding capacity and control of tumor
cell growth [1]. Most IKI family members are made up of the
assembly of evolutionarily related, so-called heavy (H) chains
with one bikunin (B) chain that, as the name says, harbors
two protease inhibitory domains of the Kunitz type. Four H
chains are currently known and designated H1^H4. One or
more of them speci¢cally participate in the structure of a
given molecule in the IKI family as exampli¢ed by the proteins
designated IKIH1,2,B (i.e. IKI itself, made up of H1+H2+B),
IKIH2,B, IKIH3,B, etc... [1]. In all mammals studied so far,
the four H chains originate from precursor polypeptides H1P^
H4P (HxPs) that are 900^930 amino acid residues long and
are encoded by four genes, ITIH1^ITIH4. The most N-termi-
nal 600 amino acid residues or so of all four HxPs are highly
similar (s 25% strictly identical residues are shared between
them within a species). They all harbor a domain, about 160
residues in length, that is similar to the so-called von Wille-
brand type A domain and hence suggests a heterophilic bind-
ing capacity of the H chains [2,3]. In contrast, the C-terminal
third of HxPs is quite variable from one precursor to another.
Indeed, it is well conserved between H1P and H3P whereas it
is more distantly related in H2P and it is completely di¡erent
in H4P [1]. Notably, a unique proline-rich domain has been
found in the C-terminus third of H4P [4]. Finally, a processing
of H1P, H2P and H3P releases their C-terminal third and
allows the N-terminal two thirds, i.e. H1, H2 and H3, to
assemble with B prior to secretion whereas H4P is not proc-
essed nor does it assemble with B. Therefore, the hallmark of
all four HxPs, and hence of the IKI family, is made of their
strongly conserved N-terminal two thirds only.
2. Poly(ADP-ribose)polymerase (PARP)
PARP is a member of a superfamily of ADP-ribosyl trans-
ferases with a shared NAD+ binding fold [5]. PARP is a
ubiquitous and chromatin-associated protein, 1014 residues
in length, that catalyses the covalent addition of ADP-ribosyl
groups from the substrate NAD+ to itself (automodi¢cation)
and to a limited number of nuclear DNA binding proteins
(heteromodi¢cation) whereby a resulting ADP-ribose polymer
eventually extends up to 20^30 U within the cell nucleus.
PARP is an essential nick sensor in cellular processes where
nicking and rejoining of DNA strands are required. These
cellular processes include di¡erentiation, proliferation and tu-
mor transformation as well as the recovery from DNA dam-
age [6^8]. PARP is well conserved from Drosophila to humans
and is comprized of three major domains, namely a N-termi-
nal DNA binding domain with two zinc ¢ngers and a bipartite
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nuclear localization signal (NLS), a central automodi¢cation
domain and a C-terminal catalytic domain that harbors a
highly conserved NAD+ binding site [7,9].
3. A protein with IKI- and PARP-related domains: PH5P
While searching for similarities in data banks with a new
version of the BLAST algorithm [10], we have noted that
within a novel human cDNA-deduced polypeptide as yet con-
sidered a PARP-like protein [11,12], two regions are very sim-
ilar to the PARP catalytic domain and the hallmark of the IKI
family, respectively. Two copies of this novel cDNA have now
been cloned by two groups including ours [11,12] and the
evidence excludes the possibility that this surprising associa-
tion of two regions, one of which occurs within a nuclear
protein and the other in a plasma protein, could result from
cloning artifacts. Also, RT-PCR experiments in our labora-
tory (not detailed) have further excluded this possibility. As
shown in Fig. 1, this novel protein is a large polypeptide with
a N-terminal area that is homologous to the PARP catalytic
domain, a central area that is homologous to the upper two
thirds of HxPs and a C-terminal area that harbors a proline-
rich domain (16% Pro residues in this domain versus 4%
everywhere else). Accordingly, this novel protein, formerly
named KIAA0177 [11], is now designated PH5P (PARP-re-
lated/IKI-related H5/proline-rich). The borders of the ¢rst two
areas in PH5P fairly match the borders previously proposed
for the catalytic domain in PARP and the hallmark of HxPs
in the IKI family [1,9]. These areas in PARP and HxPs are
encoded by a set of 12 exons each [13,14]. Therefore the
PH5P gene likely resulted, at least partly, from the assembly
of two sets of exons derived from the ancestral PARP and
ITIH genes. This process involved more than a simple region-
al duplication of either ancestor as PH5P maps to human
chromosome 13 [11,12] whereas PARPs map to chromosome
1 [13] and ITIH1^ITIH4 map to chromosome 3 or 10 [1].
Extensive amino acid sequence alignments between PH5P
and the upper two thirds of HxPs (not shown) indicate that
the closest paralog of PH5P among the ITIH genes is ITIH4.
Also, the location of a Pro-rich domain in the C-terminal area
of PH5P is reminiscent of that of another Pro-rich, yet di¡er-
ent, domain described in H4P (Fig. 1). Together, the IKI fam-
ily and the PH5P protein now identify an IKI superfamily
whose evolutionary tree is shown in Fig. 2.
4. PH5P as a DNA repair-related protein
Which functions can be ascribed to PH5P? The DPHFII
motif that is found in H1P, H2P and H3P and participates in
their intracellular assemblies with B [1] is absent at the end of
the HxP-related area in PH5P which precludes a (PH5P+B)
assembly. This conclusion also ¢ts with the liver-restricted
expression of B [1] as opposed to the ubiquitous expression
of PH5P [11]. It is unlikely that PH5P binds NAD+ as the
GXXXGKG motif required within the human PARP active
site (P885VTGYMFGKGIYFAD899, where K893 is essential
[7]) is abolished in PH5P (T467DVGNLGSGIYFSD480). Else-
where, PH5P does not have the bipartite NLS found in the N-
terminal DNA binding domain in PARP [9] but it harbors a
FEBS 21644 5-3-99
Fig. 1. Overview of PH5P primary structure and its homologies with PARP and the IKI family. The human PH5P (amino acid numbering as
in [12]) is shown as a thick straight line. PH5P areas with similarities to human PARP or H4P are detailed whereas other areas that did not re-
veal any similarity with proteins in data banks are left blank. Human PARP and H4P are depicted below PH5P. In PARP and H4P, an area
that presents an amino acid similarity with PH5P is shown as a thick horizontal line whereas all other areas (not drawn to scale) are shown at
a 45‡ angle. Symbols: stippled area, PARP catalytic domain; checkers, hallmark of HxPs in the IKI family; hatched area, von Willebrand type
A domain; closed circle, nuclear localization signal; grey area, proline-rich domain; closed box, BRCT domain; crossed hatched area, PARP
automodi¢cation domain; closed ovals, zinc ¢ngers in PARP DNA binding domain. The p values of a signi¢cant similarity between an area of
PH5P and another polypeptide (PARP, H4P) or a domain (BRCT) as found by gapped BLAST [10] or Pfam [16] searches are indicated. The
signi¢cant similarities of PH5P with the H1P, H2P and H3P polypeptides of the IKI family are not depicted.
Fig. 2. Unrooted phylogenetic tree of the IKI superfamily. This tree
is based on all available cDNA-deduced sequences covering the
upper two thirds of HxPs from human, pig and rodents as well as
their counterpart within human PH5P. The pairwise distance matrix
was calculated by the program Protdist from the PHYLIP package
(Dayho¡ option) and the neighbor joining tree was obtained by the
program Neighbor from the same package [19].
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K1237RKHRKIPFSKRK1249 sequence (closed circle in Fig. 1)
that perfectly matches the consensus for a bipartite NLS
[9,15]. Therefore, like PARP, PH5P is likely to have a nuclear
location. The von Willebrand type A domain found in PH5P
is widespread in adhesive proteins and receptors [2] and hence
its presence suggests a heterophilic binding capacity of PH5P
for a polypeptide target (yet to be identi¢ed). Finally, from a
similarity search carried out according to [16] we have found a
so-called BRCT domain covering the ¢rst 94 residues in PH5P
(Fig. 1). Single or multiple copies of such a BRCT domain
have been previously observed in many proteins (e.g. the
breast cancer-associated protein 1, the retinoblastoma protein,
p53 binding proteins and PARP) that all participate in DNA
damage-responsive checkpoints via BRCT-mediated, homo or
heterophilic protein-protein interactions [17,18]. Therefore,
PH5P can now be envisioned as a ubiquitous nuclear protein
whose von Willebrand type A and BRCT domains allow for
molecular interactions that mediate DNA repair-related func-
tions.
Acknowledgements: We are indebted to Prof. W.J. Larsen (Cincinnati)
for a critical reading of the manuscript.
References
[1] Salier, J.P., Rouet, P., Raguenez, G. and Daveau, M. (1996)
Biochem. J. 315, 1^9.
[2] Bork, P. and Rohde, K. (1991) Biochem. J. 279, 908^910.
[3] Chan, P., Risler, J.L., Raguenez, G. and Salier, J.P. (1995) Bio-
chem. J. 306, 505^512.
[4] Soury, E., Olivier, E., Daveau, M., Hiron, M., Claeyssens, S.,
Risler, J.L. and Salier, J.P. (1998) Biochem. Biophys. Res. Com-
mun. 243, 522^530.
[5] Ruf, A., Menissier-De Murcia, J., De Murcia, G.M. and Schulz,
G.E. (1996) Proc. Natl. Acad. Sci. USA 93, 7481^7485.
[6] De Murcia, G., Menissier-De Murcia, J. and Schreiber, V. (1991)
BioEssays 13, 455^462.
[7] De Murcia, G. and Menissier-De Murcia, J. (1994) Trends Bio-
chem. Sci. 19, 172^176.
[8] Le Rhun, Y., Kirkland, J.B. and Shah, G.M. (1998) Biochem.
Biophys. Res. Commun. 245, 1^10.
[9] Schreiber, V., Molinete, M., BEuf, H., De Murcia, G. and Me-
nissier-De Murcia, J. (1992) EMBO J. 11, 3263^3269.
[10] Altschul, S.F., Madden, T.L., Schaº¡er, A.A., Zhang, J., Miller,
W. and Lipman, D.J. (1997) Nucleic Acids Res. 25, 3389^3402.
[11] Nagase, T., Seki, N., Ishikawa, K., Tanaka, A. and Nomura, N.
(1996) DNA Res. 3, 17^24.
[12] Still, I.H., Vince, P. and Cowel J.K. (1998) EMBL accession
#AF057160.
[13] Auer, B., Nagl, U., Herzog, H., Schneider, R. and Schweiger, M.
(1989) DNA 8, 575^580.
[14] Diarra-Mehrpour, M., Sarafan, N., Bourguignon, J., Bonnet, F.,
Bost, F. and Martin, J.P. (1998) J. Biol. Chem. 273, 26809^
26819.
[15] Robbins, J., Dilworth, S.M., Laskey, R.A. and Dingwall, C.
(1991) Cell 64, 615^623.
[16] Sonnhammer, E.L.L., Eddy, S.R., Birney, E., Bateman, A. and
Durbin, R. (1998) Nucleic Acids Res. 26, 320^322.
[17] Bork, P., Hofmann, K., Bucher, P., Neuwald, A.F., Altschul,
S.F. and Koonin, E.V. (1997) FASEB J. 11, 68^76.
[18] Zhang, X., Morera, S., Bates, P.A., Whitehead, P.C., Co¡er,
A.I., Hainbucher, K., Nash, R.A., Sternberg, M.J.E., Lindahl,
T. and Freemont, P.S. (1998) EMBO J. 17, 6404^6411.
[19] Felsenstein, J. (1993) http://evolution.genetics.washington.edu/
phylip.
FEBS 21644 5-3-99
L. Jean et al./FEBS Letters 446 (1999) 6^88
